Clinical trialNCT06425848RecruitingObservational

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

SponsorUniversity of Kansas Medical CenterEnrollment2,000Heart Failure

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Hirak Shah, MD
University of Kansas Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Scripps Health
La Jolla, California, United States
Thomas Heywood, MD
Recruiting
Indiana University
Bloomington, Indiana, United States
Maya Guglin, MD
Recruiting
University of Kansas Medical Center
Kansas City, Kansas, United States
Hirak Shah, MD
Recruiting
Fairview Health
Maplewood, Minnesota, United States
Terrie-Ann Benjamin, MD
Not, yet, recruiting
Minneapolis Heart Institute Foundation/ Allina Health
Minneapolis, Minnesota, United States
Mosi Bennett, MD
Recruiting
Saint Luke'S Health System
Kansas City, Missouri, United States
Timothy Fendler, MD
Recruiting
University of North Carolina/ Rex Hospital, Inc.
Raleigh, North Carolina, United States
Elizabeth Volz, MS
Recruiting
Providence Heart Institute
Portland, Oregon, United States
Jacob Abraham, MD
Recruiting
Prisma Health
Columbia, South Carolina, United States
Patrick McCann, MD
Recruiting
Sanford Health
Sioux Falls, South Dakota, United States
Orvaar Jonsson, MD
Recruiting
Austin Heart
Austin, Texas, United States
Kunjan Bhatt, MD
Recruiting
Houston Methodist Debakey Heart and Vascular Center
Houston, Texas, United States
Arvind Bhimaraj, MDAshrith Guha, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 Oct 2022
Primary completion: 31 Dec 2030
Completion: 31 Dec 2030
Last update posted: 22 May 2024
Registered enrollment: 2,000
Registry id: NCT06425848

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.